Table 1. Patient sources for the subtype analysis of invasive urothelial carcinoma samples.
Muscle-invasive bladder carcinoma samples were obtained from radical cystectomy or transurethral resection patients with available disease and treatment histories, as shown.
| # | Sex | Age | Tumor stage and grade |
Tissue source | Intravesical therapy |
Neoadjuvant chemotheraphy |
Recurrence |
|---|---|---|---|---|---|---|---|
| 1 | M | 65 | T4a (High) N0 | TURB | N | N/A | Y |
| 2 | M | 61 | T4a (High) N2 | Cystectomy | N | N | N |
| 3 | M | 56 | T2 (High) | TURB | N | N/A | N |
| 4 | M | 61 | T2 (High) | TURB | N | N/A | N |
| 5 | F | 74 | T2 (High) | TURB | N | N/A | Y |
| 6 | M | 59 | T1 (High) | TURB | BCG | N/A | Y |
| 7 | M | 74 | T1 (High) | TURB | N | N/A | N |
| 8 | M | 62 | T1 (High) N0 | TURB | N | N/A | N |
| 9 | M | 59 | T3 (High) | TURB | N | N/A | Y |
| 10 | F | 49 | T2 (High) N0 | TURB | N | N/A | N |